Clayton Financial Group LLC Dexcom Inc Transaction History
Clayton Financial Group LLC
- $196 Billion
- Q4 2025
A detailed history of Clayton Financial Group LLC transactions in Dexcom Inc stock. As of the latest transaction made, Clayton Financial Group LLC holds 25 shares of DXCM stock, worth $1,451. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$1,451% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DXCM
# of Institutions
1,080Shares Held
376MCall Options Held
6.76MPut Options Held
7.24M-
Vanguard Group Inc Valley Forge, PA49.5MShares$2.87 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$979 Million0.04% of portfolio
-
Baillie Gifford & CO15.6MShares$903 Million0.79% of portfolio
-
Geode Capital Management, LLC Boston, MA11MShares$637 Million0.05% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...